Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Suppan, C; Balic, M.
Treatment options in early triple-negative breast cancer Update from the San Antonio Breast Cancer Symposium 2019.
MEMO-MAG EUR MED ONC. 2020;
Doi: 10.1007/s12254-020-00609-w
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Suppan Christoph
- Co-Autor*innen der Med Uni Graz
-
Balic Marija
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- With a main focus on the early stage triple-negative breast cancer (TNBC), new data on immunotherapy in combination with chemotherapy, the role of capecitabine, the potential of circulating tumor DNA as a predictive tool in the postneoadjuvant setting and new treatment approaches were presented and discussed at the San Antonio Breast Cancer Symposium (SABCS) 2019.
- Find related publications in this database (Keywords)
-
Immunotherapy
-
Chemotherapy
-
pCR
-
PD-L1 inhibition
-
ctDNA